Genpact has given shareholders a mixed ride, with a 23.9% gain over the past three years sitting alongside a share price around US$39 that has moved around sharply in shorter periods. With new products rolling out and fresh headlines around its operations, the question now is whether the current price is properly supported by the company's earnings power.
-
The 23.9% share price increase over three years puts real weight on the question of how much earnings strength Genpact actually offers at today's level.
-
Recent launches in agentic AI solutions and the shift toward higher value technology work may support different expectations for revenue mix and profitability, which directly feed into how much investors are prepared to pay for each dollar of earnings.
-
There is a second opinion on Genpact worth weighing. See what analysts think Genpact's shares could be worth .
The stock's next move may depend on whether its current earnings justify the valuation investors are placing on Genpact today.
If you are weighing Genpact against other earnings driven stories, it can help to line it up beside 38 profitable AI stocks that aren't just burning cash .
Is Genpact a Bargain on Earnings?
The P/E ratio is a useful shorthand for Genpact because earnings remain a key anchor for how investors look at this business. At roughly 11.3x earnings, Genpact trades well below both the Professional Services industry average of about 23.4x and a peer group nearer 18.8x. The fair P/E multiple implied by the cash flow and risk profile modelling is higher than where the stock is today, which points to the current valuation sitting on the cheaper side of that benchmark.
Because management is pushing harder into agentic AI offerings and higher value technology work, the P/E gap matters. The recent Q2 2026 update, with Advanced Technology Solutions described as growing strongly, comes alongside a multiple that still prices Genpact at a discount to peers and to the tailored fair value yardstick. For anyone comparing Genpact with other earnings driven AI and services stocks, the size of that spread is the next thing to inspect in detail. Explore the numbers behind Genpact's P/E valuation .
The Genpact Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Genpact pick up where the valuation puzzle leaves off by explaining which paths for growth, margins and earnings would need to occur for the stock to be worth meaningfully more or less than today's price. Each narrative links its figures to a specific view on how Genpact's expansion, profitability and risk profile might change, giving you a reference point you can revisit as fresh information appears on the Community page.
Community views on Genpact are split between those who see mix shift and contracts setting up more value and those who focus on execution and workplace risks as a brake.
Bull case: 7% undervalued
"The rising share of annuitized, non FTE and outcome based contracts, with non FTE revenue surpassing 50% of total revenue in Q2 2026…"
Discover why this Narrative puts Genpact at 7% undervalued .
Bear case: 9% overvalued
"Although non FTE, outcome based and consumption models already represent a significant share of revenue and generally support margin improvement, these models also shift more delivery and performance risk to Genpact…"
Explore why this Narrative puts Genpact at 9% overvalued .
One more Genpact check that belongs next to the valuation work
Price ratios and narrative cases tell only part of the story for Genpact, because professional analysts have already mapped out where they expect this business to be several years from now. Explore where analysts expect Genpact to be in a few years .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include G .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
